Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Arcus Biosciences Debt to Equity Ratio 2017-2019 | RCUS

Current and historical debt to equity ratio values for Arcus Biosciences (RCUS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arcus Biosciences debt/equity for the three months ending September 30, 2019 was 0.00.
  
Arcus Biosciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.00B $0.18B 0.00
2019-06-30 $0.00B $0.20B 0.00
2019-03-31 $0.00B $0.22B 0.00
2018-12-31 $0.00B $0.24B 0.00
2018-09-30 $0.00B $0.25B 0.00
2018-06-30 $0.00B $0.26B 0.00
2018-03-31 $0.00B $0.27B 0.00
2017-12-31 $0.00B $-0.07B 0.00
2017-09-30 $0.00B 0.00
2017-06-30 $0.00B 0.00
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.347B $0.008B
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $133.394B 15.37
CSL (CSLLY) Australia $84.649B 0.00
Gilead Sciences (GILD) United States $82.234B 10.19
Celgene (CELG) United States $76.958B 10.99
Vertex Pharmaceuticals (VRTX) United States $55.287B 56.43
Biogen (BIIB) United States $51.504B 8.84
Illumina (ILMN) United States $45.718B 50.16
Regeneron Pharmaceuticals (REGN) United States $37.820B 16.56
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.486B 12.09
Seattle Genetics (SGEN) United States $20.203B 0.00
Incyte (INCY) United States $18.942B 43.97
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.962B 0.00
Genmab (GNMSF) Denmark $13.799B 60.95
Alnylam Pharmaceuticals (ALNY) United States $10.918B 0.00
Exact Sciences (EXAS) United States $10.880B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Galapagos (GLPG) Belgium $10.106B 26.04
BeiGene (BGNE) Cayman Islands $9.682B 0.00
QIAGEN (QGEN) Netherlands $9.255B 30.18
Bio-Techne Corp (TECH) United States $8.245B 55.19
Amarin (AMRN) Ireland $8.119B 0.00
Guardant Health (GH) United States $7.358B 0.00
Sarepta Therapeutics (SRPT) United States $7.308B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.210B 0.00
Moderna (MRNA) United States $6.452B 0.00
Reata Pharmaceuticals (RETA) United States $6.202B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.713B 14.52
Medicines (MDCO) United States $5.597B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.588B 0.00
Exelixis (EXEL) United States $5.023B 14.13
Ascendis Pharma (ASND) Denmark $4.781B 0.00
China Biologic Products (CBPO) China $4.593B 25.87
Repligen (RGEN) United States $4.511B 81.75
Spark Therapeutics (ONCE) United States $4.289B 0.00
Bluebird Bio (BLUE) United States $4.094B 0.00
Blueprint Medicines (BPMC) United States $3.795B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.779B 0.00
Mirati Therapeutics (MRTX) United States $3.776B 0.00
MorphoSys AG (MOR) Germany $3.661B 0.00
Immunomedics (IMMU) United States $3.623B 0.00
Adaptive Biotechnologies (ADPT) United States $3.587B 0.00
Alkermes (ALKS) Ireland $3.143B 0.00
Genmab (GMAB) Denmark $2.907B 5.99
Halozyme Therapeutics (HALO) United States $2.806B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.800B 0.00
Emergent Biosolutions (EBS) United States $2.793B 27.75
MyoKardia (MYOK) United States $2.597B 0.00
NeoGenomics (NEO) United States $2.529B 134.56
Amicus Therapeutics (FOLD) United States $2.487B 0.00
UniQure (QURE) Netherlands $2.399B 0.00
Arena Pharmaceuticals (ARNA) United States $2.311B 5.38
Acceleron Pharma (XLRN) United States $2.293B 0.00
Zai Lab (ZLAB) China $2.243B 0.00
RA PHARMCTL INC (RARX) United States $2.198B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.166B 0.00
Cambrex (CBM) United States $2.018B 25.46
Myriad Genetics (MYGN) United States $1.869B 27.61
Insmed (INSM) United States $1.846B 0.00
Ligand Pharmaceuticals (LGND) United States $1.823B 35.06
Akcea Therapeutics (AKCA) United States $1.792B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.642B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.539B 0.00
Denali Therapeutics (DNLI) United States $1.534B 0.00
Zymeworks (ZYME) Canada $1.508B 0.00
Epizyme (EPZM) United States $1.461B 0.00
REGENXBIO (RGNX) United States $1.406B 0.00
Coherus BioSciences (CHRS) United States $1.375B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.328B 0.00
Editas Medicine (EDIT) United States $1.281B 0.00
Innoviva (INVA) United States $1.265B 3.73
Athenex (ATNX) United States $1.203B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Sangamo Therapeutics (SGMO) United States $1.122B 0.00
Arvinas (ARVN) United States $1.105B 0.00
WAVE Life Sciences (WVE) Singapore $1.101B 0.00
Fate Therapeutics (FATE) United States $1.096B 0.00
Alector (ALEC) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $1.038B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.011B 0.00
Principia Biopharma (PRNB) United States $0.983B 0.00
Cara Therapeutics (CARA) United States $0.897B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.879B 0.00
Codexis (CDXS) United States $0.875B 0.00
Anika Therapeutics (ANIK) United States $0.858B 27.84
ZIOPHARM Oncology Inc (ZIOP) United States $0.840B 0.00
Vericel (VCEL) United States $0.828B 308.83
Vanda Pharmaceuticals (VNDA) United States $0.826B 6.95
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Intellia Therapeutics (NTLA) United States $0.732B 0.00
Revance Therapeutics (RVNC) United States $0.731B 0.00
Heska (HSKA) United States $0.718B 183.44
Twist Bioscience (TWST) United States $0.713B 0.00
ANI Pharmaceuticals (ANIP) United States $0.684B 11.66
DBV Technologies S.A (DBVT) France $0.674B 0.00
MiMedx (MDXG) United States $0.659B 0.00
Precision BioSciences (DTIL) United States $0.637B 0.00
Adverum Biotechnologies (ADVM) United States $0.621B 0.00
Mesoblast (MESO) Australia $0.604B 0.00
Agenus (AGEN) United States $0.599B 0.00
UROGEN PHARMA (URGN) United States $0.589B 0.00
GENFIT S.A (GNFT) France $0.585B 0.00
Cellectis S.A (CLLS) France $0.561B 0.00
Retrophin (RTRX) United States $0.556B 0.00
BioDelivery Sciences (BDSI) United States $0.551B 0.00
Cytokineticsorporated (CYTK) United States $0.547B 0.00
Kadmon Holdings (KDMN) United States $0.538B 0.00
Stemline Therapeutics (STML) United States $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.509B 0.00
AC Immune SA (ACIU) Switzerland $0.504B 11.66
Intra-Cellular Therapies (ITCI) United States $0.497B 0.00
Dynavax Technologies (DVAX) United States $0.495B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.431B 0.00
Clovis Oncology (CLVS) United States $0.427B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.388B 2.68
Bellus Health (BLU) Canada $0.386B 0.00
Merus (MRUS) Netherlands $0.365B 0.00
PDL BioPharma (PDLI) United States $0.352B 8.80
Cellular Biomedicine (CBMG) United States $0.347B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.328B 0.00
Puma Biotechnology (PBYI) United States $0.327B 0.00
Starpharma Holdings (SPHRY) Australia $0.322B 0.00
AnaptysBio (ANAB) United States $0.300B 0.00
Compugen (CGEN) Israel $0.298B 0.00
Avid Bioservices (CDMO) United States $0.294B 0.00
Kindred Biosciences (KIN) United States $0.293B 0.00
Protagonist Therapeutics (PTGX) United States $0.289B 0.00
Pfenex (PFNX) United States $0.285B 0.00
Gritstone Oncology (GRTS) United States $0.284B 0.00
Cel-Sci (CVM) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.262B 0.00
Theratechnologies (THTX) Canada $0.262B 0.00
Geron (GERN) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
OSMOTICA PHARM (OSMT) United States $0.258B 0.00
ADMA Biologics Inc (ADMA) United States $0.255B 0.00
Scholar Rock Holding (SRRK) United States $0.245B 0.00
MannKind (MNKD) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.241B 0.00
Kamada (KMDA) Israel $0.240B 7.00
Inovio Pharmaceuticals (INO) United States $0.237B 0.00
Albireo Pharma (ALBO) United States $0.236B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.232B 0.00
XOMA (XOMA) United States $0.228B 0.00
Athersys (ATHX) United States $0.222B 0.00
Cue Biopharma (CUE) United States $0.220B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Sorrento Therapeutics (SRNE) United States $0.203B 0.00
Biofrontera AG (BFRA) Germany $0.201B 0.00
Exicure (XCUR) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.191B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.188B 0.00
Arsanis (XFOR) United States $0.179B 0.00
Affimed (AFMD) Germany $0.178B 0.00
Palatin Technologies (PTN) United States $0.178B 4.85
CorMedix Inc (CRMD) United States $0.172B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.171B 0.00
Senesco Technologies (ELOX) United States $0.171B 0.00
Dyadic (DYAI) United States $0.171B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
Alcobra (ARCT) United States $0.145B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Enzo Biochem (ENZ) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.132B 0.00
BioTime (LCTX) United States $0.128B 6.57
Northwest Biotherapeutics (NWBO) United States $0.128B 0.00
Mersana Therapeutics (MRSN) United States $0.125B 0.00
Ophthotech (ISEE) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
Emmaus Life Sciences (EMMA) United States $0.118B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.118B 0.00
Five Prime Therapeutics (FPRX) United States $0.118B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.117B 0.00
NantKwest (NK) United States $0.113B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
OvaScience (MLND) United States $0.110B 0.00
Celyad SA (CYAD) Belgium $0.109B 0.00
Aptinyx (APTX) United States $0.107B 0.00
VBI Vaccines (VBIV) United States $0.105B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.102B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.101B 0.00
Novavax (NVAX) United States $0.100B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.089B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.085B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Strongbridge Biopharma (SBBP) United States $0.081B 2.17
Acorda Therapeutics (ACOR) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.076B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Verastem (VSTM) United States $0.066B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.059B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
Checkpoint Therapeutics (CKPT) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
Orgenesis (ORGS) United States $0.054B 3.50
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.053B 0.00
Applied Genetic Technologies (AGTC) United States $0.053B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
AIT Therapeutics (XAIR) United States $0.048B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.046B 0.00
AquaBounty Technologies (AQB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.043B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.033B 0.00
Oncobiologics (OTLK) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
VistaGen Therapeutics (VTGN) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00